Tempest Therapeutics Inc Stock price
Is Tempest Therapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Tempest Therapeutics Inc Stock Analysis
Analyst Opinions
7 Analysts have issued a Tempest Therapeutics Inc forecast:
Analyst Opinions
7 Analysts have issued a Tempest Therapeutics Inc forecast:
Don't miss a Thing! We will send you all news about Tempest Therapeutics Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Tempest Therapeutics Inc Stock News
Company Profile
Tempest Therapeutics, Inc.is a clinical-stage biotechnology company. It develops small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. The company is headquartered in South San Francisco, CA.
| Head office | United States |
| CEO | Dr. Angel |
| Employees | 4 |
| Founded | 2011 |
| Website | www.tempesttx.com |


